Reply to Goel et al. 'TP53 mutation allele-burden and disease outcome in MDS/AML'
Leukemia
.
2017 Mar;31(3):767-768.
doi: 10.1038/leu.2016.257.
Epub 2016 Oct 14.
Authors
D A Sallman
1
,
R Komrokji
1
,
A List
1
,
E Padron
1
Affiliation
1
Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
PMID:
27740632
DOI:
10.1038/leu.2016.257
No abstract available
Publication types
Letter
Comment
MeSH terms
Alleles*
Humans
Leukemia, Myeloid, Acute / genetics
Mutation
Myelodysplastic Syndromes / genetics*
Tumor Suppressor Protein p53 / genetics
Substances
TP53 protein, human
Tumor Suppressor Protein p53